On March 23, Israel faces its fourth election in two years, after Prime Minister Benjamin Netanyahu's coalition with Benny Gantz's Blue and White party collapsed after just seven months. Current polling suggests neither of Israel's major political blocs can secure enough votes to form a majority.
In this episode of World Review from the New Statesman, Alona Ferber joins Jeremy Cliffe and Ido Vock to discuss Israel's complex political landscape, and ask whether anything might swing voters enough to deliver a clear election result.
***
We'd love to hear from you! Send us your You Ask Us questions at youaskus.co.uk. Find us on Twitter: @jeremycliffe, @idvck and @emilyctamkin.
Subscribing to the New Statesman helps us keep producing this podcast. You can now subscribe for 12 weeks for just £12. Visit newstatesman.com/subscribe12
More audio from the New Statesman: listen to our twice-weekly UK politics podcast The New Statesman podcast
***
Read more from the New Statesman
Germany is also preparing to go to the polls. Jeremy Cliffe has been considering the future of the current ruling party, the CDU, and reflects that they may benefit from a period in opposition.
https://www.newstatesman.com/world/europe/2021/03/merkel-era-approaches-its-end-german-left-has-several-paths-chancellery
US President Joe Biden has signed into law an historic $1.9 trillion stimulus package. The New Statesman's leader this week calls the President a quiet radical.
https://www.newstatesman.com/world/north-america/2021/03/leader-quiet-radical
Helen Thompson argues that the EU’s hollowed out democracies are a product of the utopian illusions of the 1990s.
https://www.newstatesman.com/world/europe/2021/03/why-eu-s-hollowed-out-democracies-are-product-utopian-illusions-1990s
***
People mentioned in this episode:
Jeremy Cliffe
Ido Vock
Alona Ferber
Benjamin Netanyahu
Benny Gantz
Joe Biden
Donald Trump
Topics discussed in this episode:
Israel
Palestine
Gaza strip
West Bank
Jerusalem
Two-state solution
US embassy
Peace process
Israel elections 2021
Coronavirus
Covid-19
Vaccine
","author_name":"The New Statesman"}